Kairos Pharma, Ltd KAPA IPO will take place September, 12 on the NASDAQ exchange under the ticker KAPA.
The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on March 11, 2025.
See also: Benzinga IPO Calendar
About Kairos Pharma, Ltd
Kairos Pharma, Ltd is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
